JPS63122459A - Mesh for breast wall - Google Patents

Mesh for breast wall

Info

Publication number
JPS63122459A
JPS63122459A JP61268902A JP26890286A JPS63122459A JP S63122459 A JPS63122459 A JP S63122459A JP 61268902 A JP61268902 A JP 61268902A JP 26890286 A JP26890286 A JP 26890286A JP S63122459 A JPS63122459 A JP S63122459A
Authority
JP
Japan
Prior art keywords
mesh
chest wall
months
acid
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP61268902A
Other languages
Japanese (ja)
Other versions
JPH0741063B2 (en
Inventor
義人 筏
丞烋 玄
慶彦 清水
智 渡部
達雄 中村
細井 三男
西口 清
徹 山本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gunze Ltd
Original Assignee
Gunze Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gunze Ltd filed Critical Gunze Ltd
Priority to JP61268902A priority Critical patent/JPH0741063B2/en
Publication of JPS63122459A publication Critical patent/JPS63122459A/en
Publication of JPH0741063B2 publication Critical patent/JPH0741063B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。
(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は外科手術において胸壁の欠損修復のために使用
されるメツシュの提供に関する。
DETAILED DESCRIPTION OF THE INVENTION Field of the Invention The present invention relates to the provision of a mesh for use in repairing defects in the chest wall during surgery.

(従来技術) 現在、臨床で広く用いられている胸壁補修用の補強材は
ポリプロピレン製のMarlex Mesh (C,R
(Prior art) Currently, the reinforcing material for chest wall repair that is widely used in clinical practice is Marlex Mesh (C, R
.

Bard、Inc社製、商品名)がある。(manufactured by Bard, Inc., trade name).

しかしながら、かかる従来のものは強度的には充分その
機能を果し得るが体内吸収性でないため生体組織が侵入
して胸壁を再建した後にも異物として体内に残り、少な
からず組織反応を起しつづける欠点を有する。また、成
長期の子供に適用したとき、胸壁再建後に胸壁の成長を
阻害することが知られている。
However, although these conventional devices are strong enough to perform their functions, they are not absorbable by the body, so even after the chest wall is reconstructed, living tissue invades and remains in the body as a foreign object, causing considerable tissue reactions. It has its drawbacks. It is also known to inhibit chest wall growth after chest wall reconstruction when applied to growing children.

(発明が解決しようとする問題点) 本発明はかかる点、生体内分解吸収性を特徴とする胸壁
メツシュを提供するもので、生体親和性に優れ、また、
機能を果したのち長く体内に残りつづけることがないた
め異物反応を起すことがなく、特に、成長期の子供への
適用において他に例をみない優れた効果を有するもので
ある。
(Problems to be Solved by the Invention) The present invention provides a chest wall mesh that is biodegradable and absorbable, has excellent biocompatibility, and
Since it does not remain in the body for a long time after fulfilling its function, it does not cause a foreign body reaction, and it has an unparalleled excellent effect especially when applied to growing children.

(問題を解決するための手段) しかるに、その構成において、生体吸収性の合成高分子
繊条により多孔状に編、織成されてなる生地をもって構
成されたことに特徴を有し、特に、その素材として生体
分解吸収性の高分子であるポリグリコール酸もしくはポ
リ乳酸もしくはこれらの共重合体で構成したことに特徴
を有するものである。
(Means for Solving the Problem) However, its structure is characterized by the fact that it is composed of a fabric that is knitted and woven in a porous manner using bioabsorbable synthetic polymer fibers. It is characterized in that it is made of biodegradable and absorbable polymers such as polyglycolic acid or polylactic acid, or a copolymer thereof.

(作用) 本発明メツシュが好適に適用される胸部外科領域におけ
る外科治療の例としては次のようなものがある。
(Function) Examples of surgical treatments in the thoracic surgery field to which the mesh of the present invention is suitably applied include the following.

即ち、胸壁の異常として肋骨や胸骨の異常、漏斗胸、鳩
胸、胸壁ヘルニアなどで先天性のもの。
In other words, chest wall abnormalities include rib and sternum abnormalities, pectus excavatum, pigeon chest, and chest wall hernia, which are congenital.

或はこれらの後天性のもの、また、交通事故や労務上で
の事故で胸壁に重篤な損傷を起すもの0例えば、交通事
故などの外傷で同時に片側、あるいは両側胸郭の多数の
肋骨骨折を生じ胸郭のささえがなくなるため重篤な呼吸
循環障害をきたす動揺胸郭と呼ばれるもの、さらに胸壁
の炎症や胸壁の腫瘍、かかる炎症の場合は適切な化学療
法を行えばよいが難治のものは助軟骨切除や痩孔切除な
どを行う必要があり、また、腫瘍の場合も放射線療法を
行うこともよいが大部分の限局性胸壁腫瘍では外科的切
除を行うことが最もよい治療法とされ、これらのケース
では何れも外科的な手術が必要とされている。
Or these acquired injuries, or those that cause serious damage to the chest wall due to a traffic accident or work-related accident. This is called a fluctuating thorax, which causes serious respiratory and circulation disorders due to the lack of support from the thorax, as well as inflammation of the chest wall and tumors of the chest wall.In the case of such inflammation, appropriate chemotherapy can be performed, but in cases that are difficult to treat, auxiliary cartilage is needed. It is necessary to perform excision or fistula resection, and radiation therapy may also be performed in the case of tumors, but surgical resection is considered the best treatment for most localized chest wall tumors; In all cases, surgical intervention is required.

かかる用途に適用されるメツシュは整形外科領域で用い
られる骨固定用器具はどの高い力学的強度は必要とされ
ず、組織が入り込んで切除した胸壁が再建されるまで足
がかりとなるだけでも意味があり、従って、2〜3力月
で分解吸収されるポリグリコール酸から18〜24力月
で分解吸収されるポリ−L−乳酸まで所望の使い分けが
可能である。
The mesh used for this purpose does not require any high mechanical strength compared to the bone fixation devices used in the orthopedic field, and it is meaningful just to allow tissue to enter and serve as a stepping stone until the resected chest wall is reconstructed. Therefore, it is possible to use as desired, ranging from polyglycolic acid which is decomposed and absorbed in 2 to 3 months to poly-L-lactic acid which is decomposed and absorbed in 18 to 24 months.

また、その適用は欠損部の大きさに合せて切断されたメ
ツシュを胸腔側から縫いつけて適用するものであり、か
かる素材は機部を果した後、徐々に体内に吸収され異物
として長く体内に留まることがなく、小児への適用にお
いても胸部の成長を妨げることがないため極めて理想的
である。
In addition, it is applied by sewing a mesh cut to the size of the defect from the thoracic cavity side, and after the material has been removed, it is gradually absorbed into the body and remains in the body as a foreign material for a long time. It is extremely ideal for use in children because it does not stay in place and does not hinder the growth of the chest.

以下、その構成及び適用効果等について例を挙げて説明
する。
Hereinafter, its configuration, application effects, etc. will be explained by giving examples.

[製造例11 フェノール10に対しトリクロロフェノール7の割合で
混合した溶媒中にて溶解し、これを190℃で3分間加
熱した後30℃まで冷却して測定したときの粘度(ηs
p/c)が1.5であるポリグリコール酸チップを24
5℃で溶融紡糸し、延伸して6フイラメントで120デ
ニールの糸を得た。これを4本合糸してS撚を507/
Mかけた後、105℃にて3時間熱処理した。この約4
80デニールのポリグリコール酸系を用いて14ゲージ
のトリコット編とし、編密度288g/rn’の胸壁用
メツシュとした。
[Production Example 11 Viscosity (ηs
24 polyglycolic acid chips with a p/c) of 1.5
It was melt spun at 5°C and drawn to obtain a 120 denier yarn with 6 filaments. Combine 4 of these yarns to make an S twist of 507/
After applying M, heat treatment was performed at 105° C. for 3 hours. This about 4
A 14-gauge tricot knit using 80 denier polyglycolic acid was used to make a chest wall mesh with a knitting density of 288 g/rn'.

このようにして得た胸壁用メツシュは適度の腰を有し、
以下のように優れた評価を得た。
The chest wall mesh thus obtained has a moderate waist,
It received excellent evaluations as shown below.

[in vivo分解性評価1 前記の如く構成したメツシュをl cmX 5 cmの
大きさにカットし、家兎の皮下に埋入し、1週、2週、
2力月後に層殺し、材料の分解吸収速度、組織反応をポ
リプロピレン製の市販のマーレックスメツシュ(ソフト
)との比較において評価した。
[In vivo degradability evaluation 1 The mesh constructed as described above was cut into a size of 1 cm x 5 cm, and implanted under the skin of a domestic rabbit for 1 week, 2 weeks,
After 2 months, the layer was removed, and the decomposition and absorption rate of the material and tissue reaction were evaluated in comparison with a commercially available Marex mesh (soft) made of polypropylene.

組織反応については2週間後マーレックスメツシュでは
毛細血管の侵入が見られたが1本例ではほとんどみられ
ず炎症反応の少ないことが認められた。2力月後には本
例のメツシュは溶けてなくなっていた。
Regarding the tissue reaction, although capillary invasion was observed in the Marex mesh after 2 weeks, it was hardly observed in one case, indicating that there was little inflammatory reaction. After two months, the mesh in this case had melted and disappeared.

また1強力保持率は第1表に示す通り初期及び術後に必
要とされるに十分な強力を保持し、その後分解により急
激に低下した。
In addition, as shown in Table 1, the 1-strength retention rate maintained sufficient strength to meet the initial and postoperative needs, but then rapidly decreased due to decomposition.

これに対し、従来品は一定して低い強力を維持した。In contrast, the conventional product maintained a consistently low strength.

第1表   (単位=Kgf) [実用評価] 雑種成犬の右胸壁の肋骨を切断し、胸腔内側から前記に
より構成したメツシュを縫いつけた。
Table 1 (Unit = Kgf) [Practical Evaluation] The ribs on the right chest wall of an adult mongrel dog were cut, and the mesh constructed as described above was sewn from the inside of the chest cavity.

この縫合部の状態を見るため術後3週間、lk月、2力
月、3力月目に実験犬を層殺し、縫合部の状態を観察し
た。3週間目ですでに組織が入り込んで切除した胸壁が
再建されていた。1力月後にはメツシュの目の形がまだ
見られるがメツシュそのものの強度はゼロに近い状薦で
あった。
In order to observe the condition of the sutured area, the experimental dogs were sacrificed at 3 weeks, 1 month, 2 months, and 3 months after the operation, and the condition of the suture area was observed. By the third week, tissue had already entered and the chest wall that had been removed was being rebuilt. A month later, the shape of the eye of the mesh can still be seen, but the strength of the mesh itself was close to zero.

2力月後には胸壁はほとんど完全に近い状態で再建され
ていた。尚1分解過程における周囲への組織反応は少な
く3力月後には分解吸収されてメツシュの形は全くわか
らなくなっていた。
Two months later, the battlements had been rebuilt in near-perfect condition. There was little tissue reaction to the surrounding tissue during the decomposition process, and after three months, the mesh had been decomposed and absorbed, and the shape of the mesh was no longer recognizable.

[製造例2] 分子1410000のポリ−L−乳酸チツブを230℃
で溶融紡糸し、延伸して6フイラメン)、120デニー
ルの糸を得た。これを4本合糸して50↑/MのS撚を
かけた後、105℃にて3時間熱処理した。
[Production Example 2] Poly-L-lactic acid with a molecular weight of 1,410,000 was heated at 230°C.
The yarn was melt-spun and drawn (6 filaments) to obtain a 120-denier yarn. Four of these yarns were twisted, S-twisted at 50↑/M, and then heat treated at 105° C. for 3 hours.

この約480デニールのポリ−L−乳酸系を用いて10
ゲージのトリコット編とし、編密度200g/rr/の
胸壁用メツシュを得た。
Using this approximately 480 denier poly-L-lactic acid system,
A mesh for battlements was obtained with a gauge tricot knitting and a knitting density of 200 g/rr/.

これを前記のin viマ0分解性評価と同じように1
 cmX 5 cmの大きさにカットし、家兎の皮下に
埋入し、1力月、6力月、12カ月、24カ月後に層殺
し、材料の分解吸収速度、組織反応をみた。
This was evaluated as 1 in the same way as the above in vitro degradability evaluation
It was cut to a size of cm x 5 cm and implanted subcutaneously in a domestic rabbit, and after 1 month, 6 months, 12 months, and 24 months, the layer was removed and the decomposition and absorption rate of the material and tissue reaction were observed.

その結果、1力月後に若干の血管新生が見られたが以後
は炎症反応も極めて少なく親和性は良好であった。
As a result, some angiogenesis was observed after 1 month, but thereafter there was very little inflammatory reaction and the affinity was good.

また、その強力保持率は1力月、6力月、12力月後ニ
オイテ夫h 5.5Kgf 、4.8KgF 、3.3
Kgf、 1. IKgf 。
In addition, its strong retention rate is 5.5Kgf, 4.8KgF, 3.3 after 1 month, 6 months, and 12 months.
Kgf, 1. IKgf.

であり、24力月後においてはOとなり1体内に分解吸
収されメツシュの形は全くわからなくなっていた。
However, after 24 months, it became O and was decomposed and absorbed into one body, and the shape of the mesh was completely unknown.

(発明の効果) 本発明は以上のように従来にない優れた特徴を有し、胸
壁切除部の補綴用として極めて好適に適用可能なもので
ある。
(Effects of the Invention) As described above, the present invention has excellent features not found in the prior art, and can be very suitably applied to prosthesis of a chest wall resection.

尚9例としてポリグリコール酸とポリ−し一乳酸を記述
したが、両者の共重合体によるメツシュも可能であり、
これらの組成や重合度、熱処理条件などにより分解性の
コントロールが可能なものである。
Although polyglycolic acid and poly-monolactic acid are described as nine examples, meshes made of copolymers of both are also possible.
Degradability can be controlled by controlling these compositions, degree of polymerization, heat treatment conditions, etc.

また、その編織組織は特に限定はしないが、適用上密度
が200〜300g/ゴの範囲にあるのが好適であり、
これが200g/ m”未満であると強力的に不足し、
腰がないため適、当でなく、逆に300g/ m″を越
えると硬くなりすぎるため適用したとき患部に刺激を与
え好ましくない、また、その編織組織は切断端のほつれ
などが起らぬトリコット編が特に好ましい、また、ポリ
グリゴール酸とポリ−L−乳酸或いは1両者の共重合体
による交編織も勿論可能である。
Further, the weaving structure is not particularly limited, but it is preferable for the density to be in the range of 200 to 300 g/g for the purpose of application.
If this is less than 200g/m", there is a strong shortage,
It is not suitable because it has no waist, and on the other hand, if it exceeds 300g/m, it becomes too hard and irritates the affected area when applied, which is undesirable.Also, the woven structure is a tricot that does not cause fraying at the cut ends. Knitting is particularly preferred, and interlacing knitting and weaving of polyglygolic acid, poly-L-lactic acid, or a copolymer of both is of course also possible.

本発明は以上のように従来にない優れた胸壁用メツシュ
である。
As described above, the present invention is an excellent chest wall mesh that has never existed before.

Claims (1)

【特許請求の範囲】 1、生体内分解吸収性高分子を素材とする編、織された
生地より成ることを特徴とする胸壁用メッシュ。 2、生体内分解吸収性の高分子がポリグリコール酸もし
くはポリ乳酸であることを特徴とする特許請求の範囲第
1項記載の胸壁用メッシュ。 3、生体内分解吸収性の高分子がポリグリコール酸とポ
リ乳酸の共重合体であることを特徴とする特許請求の範
囲第1項記載の胸壁用メュ。
[Claims] 1. A chest wall mesh comprising a knitted or woven fabric made of biodegradable and absorbable polymer material. 2. The chest wall mesh according to claim 1, wherein the biodegradable and absorbable polymer is polyglycolic acid or polylactic acid. 3. The chest wall mesh according to claim 1, wherein the biodegradable and absorbable polymer is a copolymer of polyglycolic acid and polylactic acid.
JP61268902A 1986-11-11 1986-11-11 Chest wall mesh Expired - Lifetime JPH0741063B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61268902A JPH0741063B2 (en) 1986-11-11 1986-11-11 Chest wall mesh

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61268902A JPH0741063B2 (en) 1986-11-11 1986-11-11 Chest wall mesh

Publications (2)

Publication Number Publication Date
JPS63122459A true JPS63122459A (en) 1988-05-26
JPH0741063B2 JPH0741063B2 (en) 1995-05-10

Family

ID=17464855

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61268902A Expired - Lifetime JPH0741063B2 (en) 1986-11-11 1986-11-11 Chest wall mesh

Country Status (1)

Country Link
JP (1) JPH0741063B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294469A (en) * 1992-06-17 1994-03-15 Mitsui Toatsu Chemicals, Incorporated Industrial woven fabric and composite sheet comprising same
WO1995008354A1 (en) * 1993-09-24 1995-03-30 Takiron Co., Ltd. Implantation material

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61181469A (en) * 1985-02-07 1986-08-14 グンゼ株式会社 Breast support material

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61181469A (en) * 1985-02-07 1986-08-14 グンゼ株式会社 Breast support material

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294469A (en) * 1992-06-17 1994-03-15 Mitsui Toatsu Chemicals, Incorporated Industrial woven fabric and composite sheet comprising same
WO1995008354A1 (en) * 1993-09-24 1995-03-30 Takiron Co., Ltd. Implantation material

Also Published As

Publication number Publication date
JPH0741063B2 (en) 1995-05-10

Similar Documents

Publication Publication Date Title
EP1646410B1 (en) Synthetic, bioabsorbable polymer materials and implants
US10994057B2 (en) Articles of poly(butylene succinate) and copolymers thereof
JP7235762B2 (en) Medical device comprising poly(butylene succinate) and copolymers thereof
US3736646A (en) Method of attaching surgical needles to multifilament polyglycolic acid absorbable sutures
EP0349505B1 (en) A novel surgical material
JP2659424B2 (en) Felt implant
JP5280839B2 (en) Absorbable / biodegradable composite yarn and property-adjusting surgical implant formed therefrom
JP4522591B2 (en) Braided surgical mesh
US3739773A (en) Polyglycolic acid prosthetic devices
DK169400B1 (en) Knitted surgical mask
JP2001025477A (en) Surgical knitted mesh
US6773459B2 (en) Medical, bioresorbable implant, process for its production and the use thereof
CA1247041A (en) Modification of polyglycolic structural elements to achieve variable in-vivo physical properties
JP2011505220A (en) Implants for parastomal hernia
CN105063875A (en) Manufacturing method for knitted mesh of prosthetic device
JP2009039511A (en) Mesh implant with interlocking knitted structure
JP2007525601A (en) Polyhydroxyalkanoate medical fabric and medical fiber
JP2011505220A5 (en)
EP3370640B1 (en) Time dependent physiologic tissue scaffold
CN114630931A (en) Medical devices comprising poly (butylene succinate) and copolymers thereof
CN107970493B (en) Absorbable plugging device
EP0050215A1 (en) Modification of polyglycolic acid to achieve variable in-vivo physical properties
Ikada Bioabsorbable fibers for medical use
JP6502342B2 (en) Absorbable poly (p-dioxanone-co-glycolide) monofilament fiber with post-implant medium-term strength maintenance
Kinoshita et al. Study on the efficacy of biodegradable polyf (l-lactide) mesh for supporting transplanted particulate cancellous bone and marrow: experiment involving subcutaneous implantation in dogs